For past Congresses, use the Browse menu.
HRES 1125
116th Congress • 2019–2021 (Ended)

Expressing support for prioritizing racial and ethnic diversity in clinical trials for therapies, diagnostics, and vaccines for COVID-19.


Organizations below reported lobbying activity that included this bill as a disclosed issue. Expand to view filing details.
Loading filings…